Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model.
APC
Asia
age–period–cohort model
breast cancer
incidence
trend
Journal
Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700
Informations de publication
Date de publication:
2019
2019
Historique:
received:
12
03
2019
accepted:
26
07
2019
entrez:
1
10
2019
pubmed:
1
10
2019
medline:
1
10
2019
Statut:
epublish
Résumé
Breast cancer is one of the rapidly increasing cancers among women and a significant cause of cancer-related morbidity and mortality worldwide. Therefore, the current study was designed to examine and compare trends of breast cancer incidence (BCI) during the observed period (1990-2015) in specific age groups and investigate age-specific, time period, and birth cohort-related effects on BCI in China, India, Pakistan, and Thailand. Data related to BCI were retrieved from the Institute for Health Metrics and Evaluation. Age-period-cohort model joint with intrinsic estimator algorithm was used to estimate the effect of age, period, and birth cohort on BCI. BCI rates were analyzed among different age groups ranging from 20 to 84 years in specified periods. Overall, results showed an increasing trend of BCI among four Asian countries during the study period especially in age groups 50 to 84 years. Higher incidence rates were observed in 2015 in the age group 70-74, 65-69, 50-54, and 60-64 in Pakistan, China, India, and Thailand, respectively. Age period cohort analysis revealed significantly raised effect of age and period and declined effect of the cohort on incidence rates. The current study reported increased BCI with time in selected four Asian countries. Overall, BCI remained high in Pakistan as compared to China, India, and Thailand. Although proper registries are not available in most of the developing Asian countries, the current study highlighted the increased incidence and may play an essential role in registries development or spreading awareness against this disease. Therefore, maintaining proper records to build registries at the national level along with advancements in breast cancer screening and treatment are highly recommended to deal with the increasing burden of this disease.
Identifiants
pubmed: 31564974
doi: 10.2147/CMAR.S208323
pii: 208323
pmc: PMC6731990
doi:
Types de publication
Journal Article
Langues
eng
Pagination
8145-8155Informations de copyright
© 2019 Mubarik et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Gynecol Oncol. 2013 Jul;24(3):249-57
pubmed: 23875075
Cancer Manag Res. 2018 Nov 23;10:6247-6255
pubmed: 30538571
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1495-506
pubmed: 26359465
Jpn J Clin Oncol. 2014 May;44(5):401-7
pubmed: 24755545
Iran J Public Health. 2015 Apr;44(4):586-7
pubmed: 26056679
Int J Environ Res Public Health. 2015 Dec 04;12(12):15409-18
pubmed: 26690183
Biomed Res Int. 2018 Mar 21;2018:5307459
pubmed: 29750160
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Prz Menopauzalny. 2015 Sep;14(3):196-202
pubmed: 26528110
Int J Equity Health. 2015 Sep 14;14:76
pubmed: 26369689
Asian Pac J Cancer Prev. 2013;14(6):3815-7
pubmed: 23886188
Asian Pac J Cancer Prev. 2009 Apr-Jun;10(2):227-30
pubmed: 19537889
CA Cancer J Clin. 2016 Jan-Feb;66(1):31-42
pubmed: 26513636
Breast Cancer Res Treat. 2017 Jul;164(1):139-147
pubmed: 28365834
Mol Biol Rep. 2018 Dec;45(6):2369-2375
pubmed: 30255276
Asian Pac J Cancer Prev. 2016;17(6):2895-9
pubmed: 27356709
Asian Pac J Cancer Prev. 2011;12(4):879-88
pubmed: 21790220
Asian Pac J Cancer Prev. 2015;16(13):5297-304
pubmed: 26225669
Eur J Cancer Prev. 2018 Jan;27(1):88-102
pubmed: 27472086
Cancer Biol Med. 2014 Jun;11(2):101-15
pubmed: 25009752
Asian Pac J Cancer Prev. 2016;17(S3):47-52
pubmed: 27165207
J Natl Cancer Inst. 2015 Apr 13;107(7):null
pubmed: 25868578
Int J Equity Health. 2014 Jan 02;13:1
pubmed: 24383432
Cancers (Basel). 2017 Aug 17;9(8):null
pubmed: 28817104
J Gynecol Oncol. 2014 Jul;25(3):174-82
pubmed: 25045429
Eur J Cancer. 2015 Sep;51(14):2058-66
pubmed: 26232859
Cancer Sci. 2010 May;101(5):1241-6
pubmed: 20219071